关注
Taek-Chin Cheong
Taek-Chin Cheong
Research Fellow, Harvard Medical School
在 childrens.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
A multifunctional core–shell nanoparticle for dendritic cell-based cancer immunotherapy
NH Cho, TC Cheong, JH Min, JH Wu, SJ Lee, D Kim, JS Yang, S Kim, ...
Nature nanotechnology 6 (10), 675-682, 2011
5592011
Simple and rapid in vivo generation of chromosomal rearrangements using CRISPR/Cas9 technology
RB Blasco, E Karaca, C Ambrogio, TC Cheong, E Karayol, VG Minero, ...
Cell reports 9 (4), 1219-1227, 2014
2402014
Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression
SJ Kim, IJ Choi, TC Cheong, SJ Lee, R Lotan, SH Park, KH Chun
Gastroenterology 138 (3), 1035-1045. e2, 2010
1632010
Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells
M Compagno, Q Wang, C Pighi, TC Cheong, FL Meng, T Poggio, ...
Nature 542 (7642), 489-493, 2017
1292017
Editing of mouse and human immunoglobulin genes by CRISPR-Cas9 system
TC Cheong, M Compagno, R Chiarle
Nature communications 7 (1), 10934, 2016
832016
Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma
M Menotti, C Ambrogio, TC Cheong, C Pighi, I Mota, SH Cassel, ...
Nature medicine 25 (1), 130-140, 2019
682019
Orientia tsutsugamushi Subverts Dendritic Cell Functions by Escaping from Autophagy and Impairing Their Migration
JH Choi, TC Cheong, NY Ha, Y Ko, CH Cho, JH Jeon, I So, IK Kim, ...
PLoS neglected tropical diseases 7 (1), e1981, 2013
612013
Silencing of galectin‐3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents
TC Cheong, JY Shin, KH Chun
Cancer science 101 (1), 94-102, 2010
542010
Galectin-3 germline variant at position 191 enhances nuclear accumulation and activation of β-catenin in gastric cancer
SJ Kim, JY Shin, TC Cheong, IJ Choi, YS Lee, SH Park, KH Chun
Clinical & experimental metastasis 28, 743-750, 2011
452011
Taurodeoxycholate increases the number of myeloid-derived suppressor cells that ameliorate sepsis in mice
S Chang, YH Kim, YJ Kim, YW Kim, S Moon, YY Lee, JS Jung, Y Kim, ...
Frontiers in immunology 9, 1984, 2018
422018
Functional manipulation of dendritic cells by photoswitchable generation of intracellular reactive oxygen species
TC Cheong, EP Shin, EK Kwon, JH Choi, KK Wang, P Sharma, KH Choi, ...
ACS chemical biology 10 (3), 757-765, 2015
382015
ERα-associated translocations underlie oncogene amplifications in breast cancer
JJK Lee, YL Jung, TC Cheong, J Espejo Valle-Inclan, C Chu, DC Gulhan, ...
Nature 618 (7967), 1024-1032, 2023
312023
CRISPR/Cas9 screens reveal multiple layers of B cell CD40 regulation
C Jiang, SJ Trudeau, TC Cheong, R Guo, M Teng, LW Wang, Z Wang, ...
Cell reports 28 (5), 1307-1322. e8, 2019
262019
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma
E Karaca Atabay, C Mecca, Q Wang, C Ambrogio, I Mota, N Prokoph, ...
Blood, The Journal of the American Society of Hematology 139 (5), 717-731, 2022
252022
Synthesis of Multifunctional Fe3O4–CdSe/ZnS Nanoclusters Coated with Lipid A toward Dendritic Cell-Based Immunotherapy
J Jeong, EK Kwon, TC Cheong, H Park, NH Cho, W Kim
ACS applied materials & interfaces 6 (7), 5297-5307, 2014
232014
Choroid plexus-CSF-targeted antioxidant therapy protects the brain from toxicity of cancer chemotherapy
A Jang, B Petrova, TC Cheong, ME Zawadzki, JK Jones, AJ Culhane, ...
Neuron 110 (20), 3288-3301. e8, 2022
162022
The CRISPR/Cas9 system as a tool to engineer chromosomal translocation in vivo
TC Cheong, RB Blasco, R Chiarle
Chromosome Translocation, 39-48, 2018
152018
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer
I Mota, E Patrucco, C Mastini, NR Mahadevan, TC Thai, E Bergaggio, ...
Nature Cancer 4 (7), 1016-1035, 2023
112023
Assessment of Cellular Uptake Efficiency According to Multiple Inhibitors of Fe3O4-Au Core-Shell Nanoparticles: Possibility to Control Specific Endocytosis in …
BG Park, YJ Kim, JH Min, TC Cheong, SH Nam, NH Cho, YK Kim, KB Lee
Nanoscale research letters 15, 1-10, 2020
102020
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma
C Pighi, TC Cheong, M Compagno, E Patrucco, M Arigoni, M Olivero, ...
Blood Advances 5 (23), 5239-5257, 2021
82021
系统目前无法执行此操作,请稍后再试。
文章 1–20